Financial Management Professionals Inc. Acquires New Shares in Privia Health Group, Inc. (NASDAQ:PRVA)

Financial Management Professionals Inc. bought a new position in Privia Health Group, Inc. (NASDAQ:PRVA) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 2,629 shares of the company’s stock, valued at approximately $51,000.

Several other hedge funds have also recently modified their holdings of the business. Canada Pension Plan Investment Board purchased a new position in Privia Health Group in the 2nd quarter worth about $26,000. GAMMA Investing LLC raised its holdings in shares of Privia Health Group by 98.7% during the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after purchasing an additional 845 shares during the last quarter. Quarry LP lifted its position in Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after purchasing an additional 2,533 shares during the period. KBC Group NV grew its position in Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after purchasing an additional 871 shares during the period. Finally, Neo Ivy Capital Management purchased a new stake in Privia Health Group during the 3rd quarter valued at $66,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Performance

Privia Health Group stock opened at $22.24 on Monday. The company’s 50 day simple moving average is $21.01 and its 200-day simple moving average is $19.62. Privia Health Group, Inc. has a 1 year low of $15.92 and a 1 year high of $23.24. The company has a market capitalization of $2.67 billion, a price-to-earnings ratio of 222.42, a price-to-earnings-growth ratio of 2.77 and a beta of 0.85.

Analysts Set New Price Targets

Several brokerages have issued reports on PRVA. JPMorgan Chase & Co. raised their target price on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Friday, November 29th. Truist Financial raised their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Macquarie started coverage on shares of Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 target price on the stock. Stephens reissued an “overweight” rating and issued a $26.00 price objective on shares of Privia Health Group in a research note on Thursday, January 2nd. Finally, KeyCorp assumed coverage on shares of Privia Health Group in a report on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price for the company. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, Privia Health Group presently has an average rating of “Buy” and a consensus target price of $24.88.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.